Everyday Health on MSN
Quitting Zepbound Leads to at Least 25 Percent Weight Regain After a Year
Most people who stopped taking their weight loss injections also experienced negative changes in blood pressure, waist size, ...
GLP-1 agonist drugs essentially mimic the hormone’s action. Quite a few have been developed, including semaglutide, ...
And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 ...
Eli Lilly and Company, along with partner institutions in the US and United Kingdom, describe how short-term pharmacologic ...
It’s not easy being one of Silicon Valley’s favorite benchmarks.
The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients. “ Ozempic is about to be ...
GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties ...
GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...
Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects. Brain scientists are looking for ways ...
Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved injectable medications revolutionizing weight management. Both belong to the incretin mimetic drug class but differ in their mechanisms ...
While Andy Richter said he exercised a lot while on 'Dancing With the Stars,' working out wasn't the only reason he lost weight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results